0      0

Stay in Control: Strategies for Successful Cell Therapy Manufacturing

Jun 29, 2022 8:45am ‐ Jun 29, 2022 9:15am

Credits: None available.


Cell & Gene Therapy manufacturing success rates have historically been challenged by lack of process controls, with failures often undetected until final product release testing. Recently, process automation has improved manufacturing success among clinical programs by reducing human error. However, commercialization of mission-critical manufacturing requires improved processes robustness and additional in-process characterization and control to deliver these needed therapies consistently.


  • Ian Gaudet, PhD, Senior Director and Site Head, San Jose Cell Manufacturing Facility, Miltenyi Biotec


Credits: None available.

You must be logged in and own this session in order to post comments.